uniQure NV (QURE)
5.78
-0.06
(-1.11%)
USD |
NASDAQ |
Nov 22, 16:00
5.775
0.00 (0.00%)
Pre-Market: 20:00
uniQure Enterprise Value: -102.39M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -102.39M |
| November 21, 2024 | -99.22M |
| November 20, 2024 | -106.29M |
| November 19, 2024 | -100.44M |
| November 18, 2024 | -82.90M |
| November 15, 2024 | -81.68M |
| November 14, 2024 | -55.11M |
| November 13, 2024 | -52.67M |
| November 12, 2024 | -56.09M |
| November 11, 2024 | -10.76M |
| November 08, 2024 | -4.419M |
| November 07, 2024 | -21.97M |
| November 06, 2024 | -35.13M |
| November 05, 2024 | -88.74M |
| November 04, 2024 | -113.12M |
| November 01, 2024 | -98.49M |
| October 31, 2024 | -105.32M |
| October 30, 2024 | -76.83M |
| October 29, 2024 | -71.22M |
| October 28, 2024 | -58.55M |
| October 25, 2024 | -65.62M |
| October 24, 2024 | -68.30M |
| October 23, 2024 | -70.49M |
| October 22, 2024 | -60.01M |
| October 21, 2024 | -62.45M |
| Date | Value |
|---|---|
| October 18, 2024 | -71.22M |
| October 17, 2024 | -78.05M |
| October 16, 2024 | -68.79M |
| October 15, 2024 | -109.24M |
| October 14, 2024 | -109.24M |
| October 11, 2024 | -108.75M |
| October 10, 2024 | -119.96M |
| October 09, 2024 | -110.70M |
| October 08, 2024 | -95.59M |
| October 07, 2024 | -124.35M |
| October 04, 2024 | -108.75M |
| October 03, 2024 | -161.88M |
| October 02, 2024 | -162.85M |
| October 01, 2024 | -158.95M |
| September 30, 2024 | -143.85M |
| September 27, 2024 | -174.54M |
| September 26, 2024 | -179.65M |
| September 25, 2024 | -187.20M |
| September 24, 2024 | -171.62M |
| September 23, 2024 | -176.00M |
| September 20, 2024 | -160.90M |
| September 19, 2024 | -145.81M |
| September 18, 2024 | -141.42M |
| September 17, 2024 | -148.24M |
| September 16, 2024 | -158.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-288.31M
Minimum
Oct 27 2023
2.892B
Maximum
Jan 09 2020
768.66M
Average
703.72M
Median
Nov 17 2022
Enterprise Value Benchmarks
| ProQR Therapeutics NV | 288.57M |
| Merus NV | 2.482B |
| argenx SE | 33.13B |
| Pharming Group | 434.45M |
| Pharvaris NV | 867.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.38M |
| Revenue (Quarterly) | 2.287M |
| Total Expenses (Quarterly) | 42.52M |
| EPS Diluted (Quarterly) | -0.91 |
| Gross Profit Margin (Quarterly) | 55.36% |
| Profit Margin (Quarterly) | -1.94K% |
| Earnings Yield | -85.81% |
| Normalized Earnings Yield | -87.86 |